Related Experiment Videos
Acute hyperglycemia abolishes ischemic preconditioning in vivo
J R Kersten1, T J Schmeling, K G Orth
1Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.
The American Journal of Physiology
|July 31, 1998
Summary
Acute hyperglycemia abolishes the protective effects of ischemic preconditioning in dogs, potentially increasing myocardial infarct size. This finding is crucial for understanding heart attack outcomes in diabetic patients.
Area of Science:
- Cardiovascular Science
- Metabolic Research
- Ischemic Injury
Background:
- Ischemic preconditioning (IP) reduces myocardial infarct size.
- Hyperglycemia is linked to increased mortality after myocardial infarction (MI).
Purpose of the Study:
- To investigate if acute hyperglycemia alters the protective effects of ischemic preconditioning.
- To determine the dose-dependent effects of hyperglycemia on myocardial infarct size.
Main Methods:
- A canine model was used with prolonged coronary artery occlusion and reperfusion.
- Ischemic preconditioning was induced via occlusion-reperfusion cycles.
- Hyperglycemia was induced using intravenous dextrose infusions (300 or 600 mg/dl).
- Infarct size was quantified using triphenyltetrazolium staining.
Main Results:
- Ischemic preconditioning significantly reduced infarct size in normoglycemic dogs (8% vs. 24%).
- Hyperglycemia (300 mg/dl) abolished the protective effect of ischemic preconditioning (30% vs. 8%).
- Profound hyperglycemia (600 mg/dl) increased infarct size (44% vs. 24%).
Conclusions:
- Acute hyperglycemia adversely modulates myocardial injury during ischemia and reperfusion.
- The protective benefits of ischemic preconditioning are lost in the presence of hyperglycemia.
- Hyperglycemia, particularly at profound levels, exacerbates myocardial damage.